SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 70.76 |
| Enterprise Value ($M) | 49.07 |
| Book Value ($M) | 73.54 |
| Book Value / Share | 2.04 |
| Price / Book | 0.96 |
| NCAV ($M) | 57.77 |
| NCAV / Share | 1.60 |
| Price / NCAV | 1.22 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.31 |
| Return on Assets (ROA) | -0.66 |
| Return on Equity (ROE) | -0.96 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.88 |
| Current Ratio | 3.88 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 91.28 |
| Assets | 107.06 |
| Liabilities | 33.52 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Highbridge Capital Management Llc | 9.20 | ||
| 13G/A | BlackRock, Inc. | 5.30 | 1.19 | |
| 13G/A | Vanguard Group Inc | 4.64 | -91.53 | |
| 13G | Stonepine Capital Management, LLC | 5.20 | ||
| 13G | Deep Track Capital, LP | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 138,555 | 414,648 | 33.42 | |
| 163,251 | 441,871 | 36.95 | |
| 149,606 | 389,630 | 38.40 | |
| 143,658 | 595,393 | 24.13 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| INKT – MiNK Therapeutics, Inc. | INM – InMed Pharmaceuticals Inc. |
| INMB – INmune Bio, Inc. | INTS – Intensity Therapeutics, Inc. |
| IPA – ImmunoPrecise Antibodies Ltd. |
Financial data and stock pages provided by
Fintel.io